Skip to main content

Ad Scientiam digitizes medical tests

The French start-up Ad Scientiam and its platform of digital pathology monitoring tools have already won over many pharmaceutical companies. Launched in multiple sclerosis, the approach is expanding to new therapeutic areas.

Read the article (in French)

Latest News

No news available.